Regulation on Payment of Health Services Provided in Clinical Research by the Social Security Institution
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
This Turkish regulation, effective from 3 March 2026, establishes the procedures for the Social Security Institution (SGK) to reimburse health services provided to general health insurance holders and their dependents participating in clinical trials. It applies exclusively to trials supported by the Turkish Health Institutes Presidency (TÜSEB) and authorized by the Ministry of Health, conducted in public hospitals and state universities. Research products themselves are excluded from reimbursement. SGK will finance services listed under Article 63(g) of Law 5510 within defined limits, but will not cover services under Article 64. Hospitals must notify SGK of the research products used, provide authorization documents, and comply fully with the Healthcare Implementation Communiqué (SUT). Any overpayments will be clawed back. Costs covered by clinical trial insurance or arising from participant injury or death are not reimbursed by SGK.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Effective date: 3 March 2026
- SGK will reimburse health services under Law 5510 Article 63(g) for TÜSEB-supported clinical trials in public hospitals and state universities
- Research products are explicitly excluded from SGK financing
+ 3 more changes with Pro
Obligations
What this law requires
Public hospitals and state universities must notify SGK of research products to be used in clinical trials at the time of application
Public hospitals and state universities must submit authorization documents from the Ministry of Health, support certificates from TÜSEB, participant information, and clinical trial duration details to SGK using SGK's specified methods
Public hospitals and state universities are responsible for the accuracy of all information and documents submitted to SGK
When invoicing SGK-financed health services provided in clinical research, public hospitals and state universities must comply with the Healthcare Implementation Communiqué (SUT) and all other applicable regulations
Public hospitals and state universities must notify SGK immediately when clinical research ends, is temporarily suspended, or is prematurely terminated